Lyterian Therapeutics focuses on biotechnology and small molecule therapeutics within the healthcare sector
Lyterian Therapeutics focuses on biotechnology and small molecule therapeutics within the healthcare sector. The company develops medicines by using protein homeostatic mechanisms to regulate genetically validated targets for treating diseases.
The top three firms on F4's Biotech & Life Sciences investor list.